Search Results - "Stordeur, Virginie"
-
1
-
2
Fel d 1 surface expression on plant‐made eBioparticles combines potent immune activation and hypoallergenicity
Published in Allergy (Copenhagen) (01-10-2022)Get full text
Journal Article -
3
Design, production and immunomodulatory potency of a novel allergen bioparticle
Published in PloS one (01-12-2020)“…Allergen immunotherapy (AIT) is the only disease-modifying treatment with evidence for sustained efficacy. However, it is poorly developed compared to…”
Get full text
Journal Article -
4
Exploring the Potentiality of a Plant Platform for Monoclonal Antibody Production in Veterinary Medicine
Published in Vaccines (Basel) (01-06-2024)“…Canine atopic dermatitis (CAD) is an allergic, inflammatory, and pruritic skin disease associated with the production of IgE antibodies against environmental…”
Get full text
Journal Article -
5
A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1
Published in The World Allergy Organization journal (01-11-2023)“…IntroductionAs the only market-authorized allergen immunotherapy (AIT) for peanut allergy is accompanied by a high risk of side effects and mainly induces…”
Get full text
Journal Article -
6
A new generation of high potency allergen bioparticles
Published in The World Allergy Organization journal (01-08-2020)Get full text
Journal Article -
7
First-in-class biologic to treat human allergy to cats
Published in Journal of allergy and clinical immunology (01-02-2024)Get full text
Journal Article -
8
A novel therapeutic approach for cat allergy using Fel d 1 expressing bioparticles
Published in Journal of allergy and clinical immunology (01-02-2023)Get full text
Journal Article -
9
Fel d 1 surface expression on plant‐made e Bioparticles combines potent immune activation and hypoallergenicity
Published in Allergy (Copenhagen) (01-10-2022)Get full text
Journal Article -
10
-
11
Rapid induction of allergen‐blocking IgG in dogs vaccinated with plant‐based, Der f 2‐expressing bioparticles
Published in Veterinary dermatology (01-12-2024)“…Background Allergen‐carrying virus‐like particles are effective and safe means of allergen immunotherapy (AIT) in rodent models. Objective To study the…”
Get full text
Journal Article -
12
Plant‐produced SARS ‐ CoV ‐2 antibody engineered towards enhanced potency and in vivo efficacy
Published in Plant biotechnology journal (19-11-2024)“…Prevention of severe COVID‐19 disease by SARS‐CoV‐2 in high‐risk patients, such as immuno‐compromised individuals, can be achieved by administration of…”
Get full text
Journal Article -
13
Preliminary indications regarding the safety and efficacy potential of allergen bearing bioparticles as an evolved form of immunotherapy
Published in Journal of allergy and clinical immunology (01-02-2018)“…The ability of these bioparticles to induce degranulation of human basophils derived from house dust mite allergic individuals was also studied. Conclusions…”
Get full text
Journal Article